Silver Grove Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
988
-18
-2% -$18.4K 0.64% 37
2026
Q1
$926K Buy
+1,006
New +$1.02M 0.74% 36
2025
Q4
Sell
-863
Closed -$658K 146
2025
Q3
$658K Buy
+863
New +$642K 0.62% 44

Other funds holding LLY

Silver Grove Financial Group's LLY Position: Q2 2026 in Review

Silver Grove Financial Group reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $18.4K and leaving 988 shares worth $1.18M. The position accounts for 0.64% of the portfolio, ranked #37.

Silver Grove Financial Group first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Silver Grove Financial Group held 988 shares of Eli Lilly worth $1.18M as of Q2 2026.
  • Silver Grove Financial Group sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 0.64% of Silver Grove Financial Group's portfolio in Q2 2026, its #37 holding.
  • Silver Grove Financial Group first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.